Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study Article Swipe
Denis Smith
,
Côme Lepage
,
Éric Vicaut
,
Sophie Dominguez
,
Romain Coriat
,
Olivier Dubreuil
,
Thierry Lecomte
,
Éric Baudin
,
Laurence Venat‐Bouvet
,
Emmanuelle Samalin
,
Alexandre Santos
,
Odile Borie
,
Ségolène Bisot-Locard
,
Bernard Goichot
,
Catherine Lombard‐Bohas
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1007/s12325-022-02103-7
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1007/s12325-022-02103-7
NCT02264665.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1007/s12325-022-02103-7
- https://link.springer.com/content/pdf/10.1007/s12325-022-02103-7.pdf
- OA Status
- hybrid
- Cited By
- 8
- References
- 20
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4223969537
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4223969537Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1007/s12325-022-02103-7Digital Object Identifier
- Title
-
Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE StudyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-04-13Full publication date if available
- Authors
-
Denis Smith, Côme Lepage, Éric Vicaut, Sophie Dominguez, Romain Coriat, Olivier Dubreuil, Thierry Lecomte, Éric Baudin, Laurence Venat‐Bouvet, Emmanuelle Samalin, Alexandre Santos, Odile Borie, Ségolène Bisot-Locard, Bernard Goichot, Catherine Lombard‐BohasList of authors in order
- Landing page
-
https://doi.org/10.1007/s12325-022-02103-7Publisher landing page
- PDF URL
-
https://link.springer.com/content/pdf/10.1007/s12325-022-02103-7.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://link.springer.com/content/pdf/10.1007/s12325-022-02103-7.pdfDirect OA link when available
- Concepts
-
Medicine, Sunitinib, Tolerability, Everolimus, Internal medicine, Neuroendocrine tumors, Discontinuation, Adverse effect, Oncology, Observational study, CancerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
8Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 6, 2024: 1, 2023: 1Per-year citation counts (last 5 years)
- References (count)
-
20Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4223969537 |
|---|---|
| doi | https://doi.org/10.1007/s12325-022-02103-7 |
| ids.doi | https://doi.org/10.1007/s12325-022-02103-7 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/35419649 |
| ids.openalex | https://openalex.org/W4223969537 |
| fwci | 1.79537287 |
| mesh[0].qualifier_ui | Q000627 |
| mesh[0].descriptor_ui | D000970 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | therapeutic use |
| mesh[0].descriptor_name | Antineoplastic Agents |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D018450 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Disease Progression |
| mesh[2].qualifier_ui | Q000627 |
| mesh[2].descriptor_ui | D000068338 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | therapeutic use |
| mesh[2].descriptor_name | Everolimus |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D006801 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Humans |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D016609 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Neoplasms, Second Primary |
| mesh[5].qualifier_ui | Q000139 |
| mesh[5].descriptor_ui | D018242 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | chemically induced |
| mesh[5].descriptor_name | Neuroectodermal Tumors, Primitive |
| mesh[6].qualifier_ui | Q000188 |
| mesh[6].descriptor_ui | D018242 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | drug therapy |
| mesh[6].descriptor_name | Neuroectodermal Tumors, Primitive |
| mesh[7].qualifier_ui | Q000188 |
| mesh[7].descriptor_ui | D018358 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | drug therapy |
| mesh[7].descriptor_name | Neuroendocrine Tumors |
| mesh[8].qualifier_ui | Q000473 |
| mesh[8].descriptor_ui | D010190 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | pathology |
| mesh[8].descriptor_name | Pancreatic Neoplasms |
| mesh[9].qualifier_ui | Q000627 |
| mesh[9].descriptor_ui | D000077210 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | therapeutic use |
| mesh[9].descriptor_name | Sunitinib |
| mesh[10].qualifier_ui | Q000627 |
| mesh[10].descriptor_ui | D000970 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | therapeutic use |
| mesh[10].descriptor_name | Antineoplastic Agents |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D018450 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Disease Progression |
| mesh[12].qualifier_ui | Q000627 |
| mesh[12].descriptor_ui | D000068338 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | therapeutic use |
| mesh[12].descriptor_name | Everolimus |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D006801 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Humans |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D016609 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Neoplasms, Second Primary |
| mesh[15].qualifier_ui | Q000139 |
| mesh[15].descriptor_ui | D018242 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | chemically induced |
| mesh[15].descriptor_name | Neuroectodermal Tumors, Primitive |
| mesh[16].qualifier_ui | Q000188 |
| mesh[16].descriptor_ui | D018242 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | drug therapy |
| mesh[16].descriptor_name | Neuroectodermal Tumors, Primitive |
| mesh[17].qualifier_ui | Q000188 |
| mesh[17].descriptor_ui | D018358 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | drug therapy |
| mesh[17].descriptor_name | Neuroendocrine Tumors |
| mesh[18].qualifier_ui | Q000473 |
| mesh[18].descriptor_ui | D010190 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | pathology |
| mesh[18].descriptor_name | Pancreatic Neoplasms |
| mesh[19].qualifier_ui | Q000627 |
| mesh[19].descriptor_ui | D000077210 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | therapeutic use |
| mesh[19].descriptor_name | Sunitinib |
| type | article |
| title | Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study |
| biblio.issue | 6 |
| biblio.volume | 39 |
| biblio.last_page | 2748 |
| biblio.first_page | 2731 |
| topics[0].id | https://openalex.org/T10754 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Neuroendocrine Tumor Research Advances |
| topics[1].id | https://openalex.org/T12334 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9988999962806702 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Lung Cancer Research Studies |
| topics[2].id | https://openalex.org/T12226 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9984999895095825 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2728 |
| topics[2].subfield.display_name | Neurology |
| topics[2].display_name | Neuroblastoma Research and Treatments |
| funders[0].id | https://openalex.org/F4320307765 |
| funders[0].ror | https://ror.org/01xdqrp08 |
| funders[0].display_name | Pfizer |
| funders[1].id | https://openalex.org/F4320307778 |
| funders[1].ror | https://ror.org/02f9zrr09 |
| funders[1].display_name | Novartis |
| is_xpac | False |
| apc_list.value | 3390 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4390 |
| apc_paid.value | 3390 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 4390 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9339824914932251 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2779490328 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8969926238059998 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q417542 |
| concepts[1].display_name | Sunitinib |
| concepts[2].id | https://openalex.org/C2778375690 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7420664429664612 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7814214 |
| concepts[2].display_name | Tolerability |
| concepts[3].id | https://openalex.org/C2779699572 |
| concepts[3].level | 2 |
| concepts[3].score | 0.7209208011627197 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q421052 |
| concepts[3].display_name | Everolimus |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.6918216943740845 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C2779066768 |
| concepts[5].level | 2 |
| concepts[5].score | 0.6875383853912354 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1981276 |
| concepts[5].display_name | Neuroendocrine tumors |
| concepts[6].id | https://openalex.org/C2778715236 |
| concepts[6].level | 2 |
| concepts[6].score | 0.6640115976333618 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q55622662 |
| concepts[6].display_name | Discontinuation |
| concepts[7].id | https://openalex.org/C197934379 |
| concepts[7].level | 2 |
| concepts[7].score | 0.5506227016448975 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[7].display_name | Adverse effect |
| concepts[8].id | https://openalex.org/C143998085 |
| concepts[8].level | 1 |
| concepts[8].score | 0.5389652252197266 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[8].display_name | Oncology |
| concepts[9].id | https://openalex.org/C23131810 |
| concepts[9].level | 2 |
| concepts[9].score | 0.46744000911712646 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q818574 |
| concepts[9].display_name | Observational study |
| concepts[10].id | https://openalex.org/C121608353 |
| concepts[10].level | 2 |
| concepts[10].score | 0.26450878381729126 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[10].display_name | Cancer |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9339824914932251 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/sunitinib |
| keywords[1].score | 0.8969926238059998 |
| keywords[1].display_name | Sunitinib |
| keywords[2].id | https://openalex.org/keywords/tolerability |
| keywords[2].score | 0.7420664429664612 |
| keywords[2].display_name | Tolerability |
| keywords[3].id | https://openalex.org/keywords/everolimus |
| keywords[3].score | 0.7209208011627197 |
| keywords[3].display_name | Everolimus |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.6918216943740845 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/neuroendocrine-tumors |
| keywords[5].score | 0.6875383853912354 |
| keywords[5].display_name | Neuroendocrine tumors |
| keywords[6].id | https://openalex.org/keywords/discontinuation |
| keywords[6].score | 0.6640115976333618 |
| keywords[6].display_name | Discontinuation |
| keywords[7].id | https://openalex.org/keywords/adverse-effect |
| keywords[7].score | 0.5506227016448975 |
| keywords[7].display_name | Adverse effect |
| keywords[8].id | https://openalex.org/keywords/oncology |
| keywords[8].score | 0.5389652252197266 |
| keywords[8].display_name | Oncology |
| keywords[9].id | https://openalex.org/keywords/observational-study |
| keywords[9].score | 0.46744000911712646 |
| keywords[9].display_name | Observational study |
| keywords[10].id | https://openalex.org/keywords/cancer |
| keywords[10].score | 0.26450878381729126 |
| keywords[10].display_name | Cancer |
| language | en |
| locations[0].id | doi:10.1007/s12325-022-02103-7 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S27230875 |
| locations[0].source.issn | 0741-238X, 1865-8652 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0741-238X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Advances in Therapy |
| locations[0].source.host_organization | https://openalex.org/P4310320330 |
| locations[0].source.host_organization_name | Adis, Springer Healthcare |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320330, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Adis, Springer Healthcare, Springer Nature |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://link.springer.com/content/pdf/10.1007/s12325-022-02103-7.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Advances in Therapy |
| locations[0].landing_page_url | https://doi.org/10.1007/s12325-022-02103-7 |
| locations[1].id | pmid:35419649 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Advances in therapy |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/35419649 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:9123044 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Adv Ther |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/9123044 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5077844357 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-3155-6709 |
| authorships[0].author.display_name | Denis Smith |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210120975 |
| authorships[0].affiliations[0].raw_affiliation_string | Oncologie digestive, Centre médico-chirurgical Magellan, Hôpital Universitaire de Bordeaux, Hôpital Haut-Lévèque, 33604, Pessac Cedex, France |
| authorships[0].institutions[0].id | https://openalex.org/I4210120975 |
| authorships[0].institutions[0].ror | https://ror.org/02bf3a828 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I3018323443, https://openalex.org/I4210120975 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Hôpital Cardiologique du Haut-Lévêque |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Denis Smith |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Oncologie digestive, Centre médico-chirurgical Magellan, Hôpital Universitaire de Bordeaux, Hôpital Haut-Lévèque, 33604, Pessac Cedex, France |
| authorships[1].author.id | https://openalex.org/A5032193447 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9211-4707 |
| authorships[1].author.display_name | Côme Lepage |
| authorships[1].affiliations[0].raw_affiliation_string | Hépato-gastro-entérologie, Hôpital Universitaire Le Bocage, Dijon, France |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Côme Lepage |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Hépato-gastro-entérologie, Hôpital Universitaire Le Bocage, Dijon, France |
| authorships[2].author.id | https://openalex.org/A5088096181 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-6303-8557 |
| authorships[2].author.display_name | Éric Vicaut |
| authorships[2].countries | FR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210097159, https://openalex.org/I4210119095 |
| authorships[2].affiliations[0].raw_affiliation_string | Unité de Recherche Clinique, Hôpital Lariboisière APHP, Paris, France |
| authorships[2].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[2].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[2].institutions[0].country_code | FR |
| authorships[2].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[2].institutions[1].id | https://openalex.org/I4210119095 |
| authorships[2].institutions[1].ror | https://ror.org/02mqtne57 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210119095 |
| authorships[2].institutions[1].country_code | FR |
| authorships[2].institutions[1].display_name | Hôpital Lariboisière |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Eric Vicaut |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Unité de Recherche Clinique, Hôpital Lariboisière APHP, Paris, France |
| authorships[3].author.id | https://openalex.org/A5110070729 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Sophie Dominguez |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I181827316 |
| authorships[3].affiliations[0].raw_affiliation_string | Hôpitaux Catholiques de Lille, Département d'Onco-hématologie, Université Catholique de Lille, Hôpital St Vincent de Paul, Lille, France |
| authorships[3].institutions[0].id | https://openalex.org/I181827316 |
| authorships[3].institutions[0].ror | https://ror.org/025s1b152 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I181827316 |
| authorships[3].institutions[0].country_code | FR |
| authorships[3].institutions[0].display_name | Université Catholique de Lille |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Sophie Dominguez |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Hôpitaux Catholiques de Lille, Département d'Onco-hématologie, Université Catholique de Lille, Hôpital St Vincent de Paul, Lille, France |
| authorships[4].author.id | https://openalex.org/A5090375155 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-4420-8340 |
| authorships[4].author.display_name | Romain Coriat |
| authorships[4].countries | FR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I204730241, https://openalex.org/I4210092774, https://openalex.org/I4210097159 |
| authorships[4].affiliations[0].raw_affiliation_string | Unité de Gastro-entérologie, Hôpital Cochin, APHP Centre, Université de Paris, Paris, France |
| authorships[4].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[4].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[4].institutions[0].country_code | FR |
| authorships[4].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[4].institutions[1].id | https://openalex.org/I4210092774 |
| authorships[4].institutions[1].ror | https://ror.org/00ph8tk69 |
| authorships[4].institutions[1].type | healthcare |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210092774, https://openalex.org/I4210097159, https://openalex.org/I4210124464 |
| authorships[4].institutions[1].country_code | FR |
| authorships[4].institutions[1].display_name | Hôpital Cochin |
| authorships[4].institutions[2].id | https://openalex.org/I204730241 |
| authorships[4].institutions[2].ror | https://ror.org/05f82e368 |
| authorships[4].institutions[2].type | education |
| authorships[4].institutions[2].lineage | https://openalex.org/I204730241 |
| authorships[4].institutions[2].country_code | FR |
| authorships[4].institutions[2].display_name | Université Paris Cité |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Romain Coriat |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Unité de Gastro-entérologie, Hôpital Cochin, APHP Centre, Université de Paris, Paris, France |
| authorships[5].author.id | https://openalex.org/A5083396561 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-0525-0423 |
| authorships[5].author.display_name | Olivier Dubreuil |
| authorships[5].countries | FR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210113318 |
| authorships[5].affiliations[0].raw_affiliation_string | Oncologie médicale, Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France |
| authorships[5].institutions[0].id | https://openalex.org/I4210113318 |
| authorships[5].institutions[0].ror | https://ror.org/01zwdgr60 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210113318 |
| authorships[5].institutions[0].country_code | FR |
| authorships[5].institutions[0].display_name | Groupe Hospitalier Diaconesses Croix Saint-Simon |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Olivier Dubreuil |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Oncologie médicale, Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France |
| authorships[6].author.id | https://openalex.org/A5084815041 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-5093-0212 |
| authorships[6].author.display_name | Thierry Lecomte |
| authorships[6].countries | FR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210095477 |
| authorships[6].affiliations[0].raw_affiliation_string | Département d' Hépato-gastro-entérologie et Oncologie digestive, CHRU de Tours, Tours, France |
| authorships[6].institutions[0].id | https://openalex.org/I4210095477 |
| authorships[6].institutions[0].ror | https://ror.org/00jpq0w62 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210095477 |
| authorships[6].institutions[0].country_code | FR |
| authorships[6].institutions[0].display_name | Centre Hospitalier Universitaire de Tours |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Thierry Lecomte |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Département d' Hépato-gastro-entérologie et Oncologie digestive, CHRU de Tours, Tours, France |
| authorships[7].author.id | https://openalex.org/A5067116958 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-2198-3582 |
| authorships[7].author.display_name | Éric Baudin |
| authorships[7].countries | FR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I2801843802 |
| authorships[7].affiliations[0].raw_affiliation_string | Institut Gustave Roussy, Service de Médecine Nucléaire, Villejuif, France |
| authorships[7].institutions[0].id | https://openalex.org/I2801843802 |
| authorships[7].institutions[0].ror | https://ror.org/0321g0743 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I2801843802 |
| authorships[7].institutions[0].country_code | FR |
| authorships[7].institutions[0].display_name | Institut Gustave Roussy |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Eric Baudin |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Institut Gustave Roussy, Service de Médecine Nucléaire, Villejuif, France |
| authorships[8].author.id | https://openalex.org/A5057225332 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-0716-2550 |
| authorships[8].author.display_name | Laurence Venat‐Bouvet |
| authorships[8].countries | FR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210159361 |
| authorships[8].affiliations[0].raw_affiliation_string | Département d'Oncologie, Hôpital Dupuytren, Limoges, France |
| authorships[8].institutions[0].id | https://openalex.org/I4210159361 |
| authorships[8].institutions[0].ror | https://ror.org/053385a79 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210130325, https://openalex.org/I4210159361 |
| authorships[8].institutions[0].country_code | FR |
| authorships[8].institutions[0].display_name | Hôpital Dupuytren |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Laurence Venat Bouvet |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Département d'Oncologie, Hôpital Dupuytren, Limoges, France |
| authorships[9].author.id | https://openalex.org/A5028431629 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Emmanuelle Samalin |
| authorships[9].countries | FR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I19894307, https://openalex.org/I4210140335 |
| authorships[9].affiliations[0].raw_affiliation_string | Département d'Oncologie médicale, Institut du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France |
| authorships[9].institutions[0].id | https://openalex.org/I4210140335 |
| authorships[9].institutions[0].ror | https://ror.org/03capj968 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I154526488, https://openalex.org/I19894307, https://openalex.org/I4210140335, https://openalex.org/I4210141925, https://openalex.org/I4387154388 |
| authorships[9].institutions[0].country_code | FR |
| authorships[9].institutions[0].display_name | Institut de Recherche en Cancérologie de Montpellier |
| authorships[9].institutions[1].id | https://openalex.org/I19894307 |
| authorships[9].institutions[1].ror | https://ror.org/051escj72 |
| authorships[9].institutions[1].type | education |
| authorships[9].institutions[1].lineage | https://openalex.org/I19894307 |
| authorships[9].institutions[1].country_code | FR |
| authorships[9].institutions[1].display_name | Université de Montpellier |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Emmanuelle Samalin |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Département d'Oncologie médicale, Institut du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France |
| authorships[10].author.id | https://openalex.org/A5082539415 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-1519-3231 |
| authorships[10].author.display_name | Alexandre Santos |
| authorships[10].countries | FR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210092929 |
| authorships[10].affiliations[0].raw_affiliation_string | Novartis Oncology, Rueil-Malmaison, France |
| authorships[10].institutions[0].id | https://openalex.org/I4210092929 |
| authorships[10].institutions[0].ror | https://ror.org/00geypp27 |
| authorships[10].institutions[0].type | company |
| authorships[10].institutions[0].lineage | https://openalex.org/I1283582996, https://openalex.org/I4210092929 |
| authorships[10].institutions[0].country_code | FR |
| authorships[10].institutions[0].display_name | Novartis (France) |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Alexandre Santos |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Novartis Oncology, Rueil-Malmaison, France |
| authorships[11].author.id | https://openalex.org/A5089233894 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Odile Borie |
| authorships[11].countries | FR |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210118061 |
| authorships[11].affiliations[0].raw_affiliation_string | Pfizer Oncology, Paris, France |
| authorships[11].institutions[0].id | https://openalex.org/I4210118061 |
| authorships[11].institutions[0].ror | https://ror.org/02c9yny10 |
| authorships[11].institutions[0].type | company |
| authorships[11].institutions[0].lineage | https://openalex.org/I180857899, https://openalex.org/I4210118061 |
| authorships[11].institutions[0].country_code | FR |
| authorships[11].institutions[0].display_name | Pfizer (France) |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Odile Borie |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Pfizer Oncology, Paris, France |
| authorships[12].author.id | https://openalex.org/A5032836718 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5619-9758 |
| authorships[12].author.display_name | Ségolène Bisot-Locard |
| authorships[12].countries | FR |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210092929 |
| authorships[12].affiliations[0].raw_affiliation_string | Novartis Oncology, Rueil-Malmaison, France |
| authorships[12].institutions[0].id | https://openalex.org/I4210092929 |
| authorships[12].institutions[0].ror | https://ror.org/00geypp27 |
| authorships[12].institutions[0].type | company |
| authorships[12].institutions[0].lineage | https://openalex.org/I1283582996, https://openalex.org/I4210092929 |
| authorships[12].institutions[0].country_code | FR |
| authorships[12].institutions[0].display_name | Novartis (France) |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Ségolène Bisot-Locard |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Novartis Oncology, Rueil-Malmaison, France |
| authorships[13].author.id | https://openalex.org/A5038612569 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-7794-1683 |
| authorships[13].author.display_name | Bernard Goichot |
| authorships[13].countries | FR |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210157127 |
| authorships[13].affiliations[0].raw_affiliation_string | Département de Médecine interne, Hôpital Universitaire Hautepierre, Strasbourg, France |
| authorships[13].institutions[0].id | https://openalex.org/I4210157127 |
| authorships[13].institutions[0].ror | https://ror.org/04e1w6923 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210145324, https://openalex.org/I4210157127 |
| authorships[13].institutions[0].country_code | FR |
| authorships[13].institutions[0].display_name | Hôpital d'Hautepierre |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Bernard Goichot |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Département de Médecine interne, Hôpital Universitaire Hautepierre, Strasbourg, France |
| authorships[14].author.id | https://openalex.org/A5050532099 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-3896-4588 |
| authorships[14].author.display_name | Catherine Lombard‐Bohas |
| authorships[14].countries | FR |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210100596, https://openalex.org/I4210123600 |
| authorships[14].affiliations[0].raw_affiliation_string | Service d'Oncologie Médicale Hôpital Edouard Herriot, GHC, Hospices Civils de Lyon, Lyon, France |
| authorships[14].institutions[0].id | https://openalex.org/I4210100596 |
| authorships[14].institutions[0].ror | https://ror.org/01502ca60 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210100596 |
| authorships[14].institutions[0].country_code | FR |
| authorships[14].institutions[0].display_name | Hospices Civils de Lyon |
| authorships[14].institutions[1].id | https://openalex.org/I4210123600 |
| authorships[14].institutions[1].ror | https://ror.org/02qt1p572 |
| authorships[14].institutions[1].type | healthcare |
| authorships[14].institutions[1].lineage | https://openalex.org/I4210100596, https://openalex.org/I4210123600 |
| authorships[14].institutions[1].country_code | FR |
| authorships[14].institutions[1].display_name | Hôpital Edouard Herriot |
| authorships[14].author_position | last |
| authorships[14].raw_author_name | Catherine Lombard-Bohas |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Service d'Oncologie Médicale Hôpital Edouard Herriot, GHC, Hospices Civils de Lyon, Lyon, France |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://link.springer.com/content/pdf/10.1007/s12325-022-02103-7.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10754 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Neuroendocrine Tumor Research Advances |
| related_works | https://openalex.org/W1975744019, https://openalex.org/W2035240798, https://openalex.org/W2241969517, https://openalex.org/W3136248377, https://openalex.org/W2743879516, https://openalex.org/W2590451496, https://openalex.org/W2130893829, https://openalex.org/W2792428998, https://openalex.org/W2719368655, https://openalex.org/W2560068745 |
| cited_by_count | 8 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 6 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1007/s12325-022-02103-7 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S27230875 |
| best_oa_location.source.issn | 0741-238X, 1865-8652 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0741-238X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Advances in Therapy |
| best_oa_location.source.host_organization | https://openalex.org/P4310320330 |
| best_oa_location.source.host_organization_name | Adis, Springer Healthcare |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320330, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Adis, Springer Healthcare, Springer Nature |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s12325-022-02103-7.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Advances in Therapy |
| best_oa_location.landing_page_url | https://doi.org/10.1007/s12325-022-02103-7 |
| primary_location.id | doi:10.1007/s12325-022-02103-7 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S27230875 |
| primary_location.source.issn | 0741-238X, 1865-8652 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0741-238X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Advances in Therapy |
| primary_location.source.host_organization | https://openalex.org/P4310320330 |
| primary_location.source.host_organization_name | Adis, Springer Healthcare |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320330, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Adis, Springer Healthcare, Springer Nature |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s12325-022-02103-7.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Advances in Therapy |
| primary_location.landing_page_url | https://doi.org/10.1007/s12325-022-02103-7 |
| publication_date | 2022-04-13 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W2025847850, https://openalex.org/W2149214723, https://openalex.org/W1968684554, https://openalex.org/W1975493203, https://openalex.org/W2160463900, https://openalex.org/W1536690700, https://openalex.org/W1973577894, https://openalex.org/W2126945216, https://openalex.org/W3012964752, https://openalex.org/W2158474413, https://openalex.org/W2115686439, https://openalex.org/W4246839970, https://openalex.org/W3155849252, https://openalex.org/W2406389797, https://openalex.org/W3015314028, https://openalex.org/W2819457658, https://openalex.org/W2136272158, https://openalex.org/W3044794930, https://openalex.org/W3212814734, https://openalex.org/W2141467520 |
| referenced_works_count | 20 |
| abstract_inverted_index.NCT02264665. | 0 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 15 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.5199999809265137 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.79537618 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |